Many studies have been done addressing this issue. According to a study by the General Accounting Office, Americans pay 32% more for similar medications than Canadians. In 2015, a study by the Kaiser Foundation found that the average cost for Cymbalta in the USA was 75% higher than in Canada (Do, 2016). Moreover, in 2012 of the twelve drugs approved by the US Food and Drug Administration (FDA) for various cancers, eleven of them cost more than $100,000 per year. Overall, cancer drug prices are 20%-40% lower in European countries than in the United States. Not only are the prices of medications for cancer rising but also for other serious conditions such as hepatitis and multiple sclerosis. In fact, people with insurance are being affected by the high cost of prescription medications. This problem is causing insurance companies to limit access to expensive medications resulting in many people not obtaining
Many studies have been done addressing this issue. According to a study by the General Accounting Office, Americans pay 32% more for similar medications than Canadians. In 2015, a study by the Kaiser Foundation found that the average cost for Cymbalta in the USA was 75% higher than in Canada (Do, 2016). Moreover, in 2012 of the twelve drugs approved by the US Food and Drug Administration (FDA) for various cancers, eleven of them cost more than $100,000 per year. Overall, cancer drug prices are 20%-40% lower in European countries than in the United States. Not only are the prices of medications for cancer rising but also for other serious conditions such as hepatitis and multiple sclerosis. In fact, people with insurance are being affected by the high cost of prescription medications. This problem is causing insurance companies to limit access to expensive medications resulting in many people not obtaining